KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $58.40 $79.59 Thursday, 25th Apr 2024 EXAS stock ended at $58.79. This is 7.04% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.97% from a day low at $58.40 to a day high of $62.47.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Jan 08, 2024 $70.50 $70.72 $67.14 $70.57 3 349 685
Jan 05, 2024 $70.24 $73.67 $70.13 $73.20 1 957 649
Jan 04, 2024 $69.29 $71.85 $69.01 $71.23 1 767 247
Jan 03, 2024 $72.17 $72.36 $69.33 $69.94 1 708 696
Jan 02, 2024 $73.50 $76.60 $73.32 $73.77 1 234 997
Dec 29, 2023 $75.60 $76.18 $73.31 $73.98 985 534
Dec 28, 2023 $75.31 $76.82 $75.16 $75.72 1 169 179
Dec 27, 2023 $76.00 $77.42 $75.13 $75.68 1 240 005
Dec 26, 2023 $74.66 $76.12 $73.87 $75.65 1 240 493
Dec 22, 2023 $71.97 $74.71 $71.43 $73.51 2 552 595
Dec 21, 2023 $68.50 $71.64 $68.50 $71.43 1 913 371
Dec 20, 2023 $73.80 $76.80 $67.25 $67.30 3 520 931
Dec 19, 2023 $65.48 $71.00 $65.11 $69.43 3 111 445
Dec 18, 2023 $66.32 $66.82 $64.18 $64.60 2 017 273
Dec 15, 2023 $68.15 $68.15 $65.35 $65.90 2 443 060
Dec 14, 2023 $69.68 $72.13 $67.31 $67.80 2 125 361
Dec 13, 2023 $66.11 $68.01 $63.80 $67.71 1 719 717
Dec 12, 2023 $65.22 $65.55 $62.62 $65.52 2 329 122
Dec 11, 2023 $64.58 $65.59 $63.00 $65.06 1 643 246
Dec 08, 2023 $63.85 $65.54 $63.42 $64.72 1 245 239
Dec 07, 2023 $65.27 $65.43 $64.36 $64.96 915 281
Dec 06, 2023 $65.50 $66.75 $64.36 $65.16 1 176 332
Dec 05, 2023 $64.55 $65.41 $63.24 $64.77 1 167 300
Dec 04, 2023 $66.84 $67.27 $64.41 $65.66 1 349 177
Dec 01, 2023 $63.80 $67.03 $62.76 $67.03 1 647 482
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT